US equities |
SPCX $167.68 ▲+5.48% NVDA $236.84 ▲+1.24% MU $1,068.30 ▼-0.61% TSLA $379.07 ▲+2.29% MSFT $526.62 ▲+1.76% SNDK $1,712.65 ▼-0.43% INTC $117.06 ▼-1.90% META $744.85 ▲+2.30%
FinancialContent

Sera Prognostics, Inc. - Class A Common Stock (NQ:SERA)

2.150 +0.060 (+2.87%)
Delayed Quote Updated: 12:45 PM EDT, Oct 5, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Sera Prognostics, Inc. - Class A Common Stock

News headline image
Sera Prognostics (NASDAQ: SERA) Releases Positive Data from AVERT PRETERM Trial
Sera Prognostics, Inc. (NASDAQ: SERA) is engaged as a health diagnostics company, which is focused around developing treatments and solutions 
Via Spotlight Growth